Tonstad, Serena <br/><br/>
Rimonabant: a cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors.  [electronic resource] 

 -  Nutrition, metabolism, and cardiovascular diseases : NMCD  Mar 2006 
 - 156-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0939-4753 
<br/><br/><label>Standard No.: </label>10.1016/j.numecd.2005.10.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cannabinoid Receptor Antagonists<br/>Cardiovascular Diseases--etiology<br/>Clinical Trials, Phase III as Topic<br/>Diabetes Mellitus, Type 2--complications<br/>Humans<br/>Hyperlipidemias--complications<br/>Metabolic Syndrome--complications<br/>Obesity--complications<br/>Piperidines--pharmacology<br/>Pyrazoles--pharmacology<br/>Rimonabant<br/>Risk Factors<br/>Smoking Cessation<br/>Tobacco Use Disorder--drug therapy<br/>Treatment Outcome<br/>Weight Gain--drug effects